Indolidone Derivatives For The Treatment Or Prevention Of Fibrotic Diseases

Patent No. EP1830843 (titled "Indolidone Derivatives For The Treatment Or Prevention Of Fibrotic Diseases") was filed by Boehringer Ingelheim on Dec 21, 2005. The application was issued on Nov 7, 2012.

Patent Summary

UPC Cases New

Latest UPC cases involving this patent.

Case NumberFiling DatePlaintiffProceeding Type
UPC_CFI_858/2025Sep 12, 2025Boehringer IngelheimInfringement
UPC_COA_446/2025May 23, 2025Boehringer IngelheimAppeal
UPC_CFI_41/2025Jan 22, 2025Boehringer IngelheimProvisional Measures

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SANDOZAug 7, 2013BEST

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1830843

BOEHRINGER INGELHEIM
Application Number
EP05823930A
Filing Date
Dec 21, 2005
Status
Opposition Rejected
Publication Date
Nov 7, 2012